Verastem reported $66.79M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
AbbVie USD 72.86B 5.36B Mar/2026
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
AstraZeneca USD 32.24B 1.68B Jun/2026
Curis USD 0 0 Jun/2022
Cytokinetics USD 1.29B 4.48M Mar/2026
Gilead Sciences USD 22.17B 2.76B Mar/2026
Incyte USD 38.27M 1.16M Jun/2026
Laboratory Of America USD 7.24B 714.6M Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 63.19B 536M Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
TG Therapeutics USD 754.44M 884K Jun/2026
Verastem USD 66.79M 26.7M Sep/2024